We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
AstroNova
ALOT
$223M
| $214K | ﹤0.01% |
+26,702
| New | +$194K |
|
952
CACI
CACI
$10.8B
| $214K | ﹤0.01% |
+1,005
| New | +$217K |
|
953
STRATTEC Security
STRT
$376M
| $213K | ﹤0.01% |
10,708
| – | – |
|
|
KE
954
Kimball Electronics
KE
$564M
| $212K | ﹤0.01% |
18,303
+7,179
| +65% | +$94.1K |
|
955
Markel Group
MKL
$25.2B
| $212K | ﹤0.01% |
218
-812
| -79% | -$825K |
|
956
Outlook Therapeutics
OTLK
$187M
| $212K | ﹤0.01% |
+14,737
| New | +$328K |
|
957
Xeris Biopharma Holdings
XERS
$1.45B
| $210K | ﹤0.01% |
35,451
-17,992
| -34% | -$71.9K |
|
958
Artivion
AORT
$1.34B
| $208K | ﹤0.01% |
+11,268
| New | +$215K |
|
|
GBL
959
DELISTED
GAMCO Investors, Inc.
GBL
| $205K | ﹤0.01% |
+17,751
| New | +$223K |
|
960
BridgeBio Pharma
BBIO
$16.4B
| $203K | ﹤0.01% |
5,422
-10,566
| -66% | -$332K |
|
961
OneWater Marine
ONEW
$211M
| $201K | ﹤0.01% |
+9,791
| New | +$247K |
|
|
AAN.A
962
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $201K | ﹤0.01% |
3,553
-60,260
| -94% | -$3.41M |
|
963
Harvard Bioscience
HBIO
$27.6M
| $198K | ﹤0.01% |
6,563
-292
| -4% | -$9.82K |
|
964
Graham Corp
GHM
$1.03B
| $191K | ﹤0.01% |
14,922
-6,463
| -30% | -$84.7K |
|
|
MCBC
965
DELISTED
Macatawa Bank Corp
MCBC
| $188K | ﹤0.01% |
28,739
-6,946
| -19% | -$50.1K |
|
|
PTE
966
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $187K | ﹤0.01% |
+7,190
| New | +$237K |
|
|
HOME
967
DELISTED
At Home Group Inc.
HOME
| $187K | ﹤0.01% |
+12,565
| New | +$166K |
|
|
PTVCB
968
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $187K | ﹤0.01% |
14,258
-3,888
| -21% | -$55.7K |
|
|
USAK
969
DELISTED
USA Truck Inc
USAK
| $185K | ﹤0.01% |
+19,547
| New | +$199K |
|
970
OP Bancorp
OPBK
$235M
| $184K | ﹤0.01% |
32,109
-29,611
| -48% | -$186K |
|
|
PCTI
971
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $176K | ﹤0.01% |
31,137
-5,960
| -16% | -$37.3K |
|
|
ARAV
972
DELISTED
Aravive, Inc. Common Stock
ARAV
| $175K | ﹤0.01% |
37,335
+23,209
| +164% | +$165K |
|
|
WSR
973
DELISTED
Whitestone REIT
WSR
| $174K | ﹤0.01% |
28,986
| – | – |
|
974
Nature's Sunshine
NATR
$362M
| $169K | ﹤0.01% |
14,643
-8,802
| -38% | -$94.2K |
|
975
Corvus Pharmaceuticals
CRVS
$1.1B
| $168K | ﹤0.01% |
41,968
-36,666
| -47% | -$146K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.